BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31151136)

  • 21. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme.
    Vekrellis K; Ye Z; Qiu WQ; Walsh D; Hartley D; Chesneau V; Rosner MR; Selkoe DJ
    J Neurosci; 2000 Mar; 20(5):1657-65. PubMed ID: 10684867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
    Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degradation of Alzheimer's Amyloid-β by a Catalytically Inactive Insulin-Degrading Enzyme.
    Sahoo BR; Panda PK; Liang W; Tang WJ; Ahuja R; Ramamoorthy A
    J Mol Biol; 2021 Jun; 433(13):166993. PubMed ID: 33865867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New Insights into Epigenetic and Pharmacological Regulation of Amyloid-Degrading Enzymes.
    Nalivaeva NN; Belyaev ND; Turner AJ
    Neurochem Res; 2016 Mar; 41(3):620-30. PubMed ID: 26376806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatostatin modulates insulin-degrading-enzyme metabolism: implications for the regulation of microglia activity in AD.
    Tundo G; Ciaccio C; Sbardella D; Boraso M; Viviani B; Coletta M; Marini S
    PLoS One; 2012; 7(4):e34376. PubMed ID: 22509294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid beta-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin.
    Malito E; Hulse RE; Tang WJ
    Cell Mol Life Sci; 2008 Aug; 65(16):2574-85. PubMed ID: 18470479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptidases, proteases and amyloid beta-peptide catabolism.
    Hersh LB
    Curr Pharm Des; 2003; 9(6):449-54. PubMed ID: 12570808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRI2 protein regulates β-amyloid degradation by increasing levels of secreted insulin-degrading enzyme (IDE).
    Kilger E; Buehler A; Woelfing H; Kumar S; Kaeser SA; Nagarathinam A; Walter J; Jucker M; Coomaraswamy J
    J Biol Chem; 2011 Oct; 286(43):37446-57. PubMed ID: 21873424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of proteases to fibrillar amyloid-beta protein and its inhibition by Congo red.
    Chander H; Chauhan A; Chauhan V
    J Alzheimers Dis; 2007 Nov; 12(3):261-9. PubMed ID: 18057560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer's Disease.
    Kim N; Lee HJ
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accumulation of BRI2-BRICHOS ectodomain correlates with a decreased clearance of Aβ by insulin degrading enzyme (IDE) in Alzheimer's disease.
    Del Campo M; Stargardt A; Veerhuis R; Reits E; Teunissen CE
    Neurosci Lett; 2015 Mar; 589():47-51. PubMed ID: 25597881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of enzymatic degradation of amyloid Beta microfibrils generating nanofilaments and nanospheres related to cytotoxicity.
    Numata K; Kaplan DL
    Biochemistry; 2010 Apr; 49(15):3254-60. PubMed ID: 20196618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of growth differentiation factor-15 secreted by human umbilical cord blood-derived mesenchymal stem cells on amyloid beta levels in in vitro and in vivo models of Alzheimer's disease.
    Kim DH; Lee D; Lim H; Choi SJ; Oh W; Yang YS; Chang JH; Jeon HB
    Biochem Biophys Res Commun; 2018 Oct; 504(4):933-940. PubMed ID: 30224067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leptin inhibits amyloid β-protein degradation through decrease of neprilysin expression in primary cultured astrocytes.
    Yamamoto N; Tanida M; Ono Y; Kasahara R; Fujii Y; Ohora K; Suzuki K; Sobue K
    Biochem Biophys Res Commun; 2014 Feb; 445(1):214-7. PubMed ID: 24508800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aβ-degrading enzymes: potential for treatment of Alzheimer disease.
    Miners JS; Barua N; Kehoe PG; Gill S; Love S
    J Neuropathol Exp Neurol; 2011 Nov; 70(11):944-59. PubMed ID: 22002425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design of Peptide Substrate for Sensitively and Specifically Detecting Two Aβ-Degrading Enzymes: Neprilysin and Angiotensin-Converting Enzyme.
    Chen PT; Chen CL; Lin LT; Lo CH; Hu CJ; Chen RP; Wang SS
    PLoS One; 2016; 11(4):e0153360. PubMed ID: 27096746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A highly sensitive peptide substrate for detecting two Aß-degrading enzymes: neprilysin and insulin-degrading enzyme.
    Chen PT; Liao TY; Hu CJ; Wu ST; Wang SS; Chen RP
    J Neurosci Methods; 2010 Jun; 190(1):57-62. PubMed ID: 20435063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common Pesticide, Dichlorodiphenyltrichloroethane (DDT), Increases Amyloid-β Levels by Impairing the Function of ABCA1 and IDE: Implication for Alzheimer's Disease.
    Li G; Kim C; Kim J; Yoon H; Zhou H; Kim J
    J Alzheimers Dis; 2015; 46(1):109-22. PubMed ID: 25720399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toward Allosterically Increased Catalytic Activity of Insulin-Degrading Enzyme against Amyloid Peptides.
    Kurochkin IV; Guarnera E; Wong JH; Eisenhaber F; Berezovsky IN
    Biochemistry; 2017 Jan; 56(1):228-239. PubMed ID: 27982586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphorylation of amyloid-β peptide at serine 8 attenuates its clearance via insulin-degrading and angiotensin-converting enzymes.
    Kumar S; Singh S; Hinze D; Josten M; Sahl HG; Siepmann M; Walter J
    J Biol Chem; 2012 Mar; 287(11):8641-51. PubMed ID: 22267728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.